Chicago Capital LLC grew its position in NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 0.7% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 803,859 shares of the computer hardware maker’s stock after acquiring an additional 5,926 shares during the period. NVIDIA comprises 3.1% of Chicago Capital LLC’s portfolio, making the stock its 4th largest holding. Chicago Capital LLC’s holdings in NVIDIA were worth $127,002,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently made changes to their positions in NVDA. Kathleen S. Wright Associates Inc. lifted its stake in shares of NVIDIA by 169.3% in the first quarter. Kathleen S. Wright Associates Inc. now owns 404 shares of the computer hardware maker’s stock valued at $44,000 after purchasing an additional 254 shares during the period. Barnes Dennig Private Wealth Management LLC purchased a new stake in NVIDIA in the first quarter valued at approximately $51,000. Bruce G. Allen Investments LLC grew its holdings in NVIDIA by 198.2% in the first quarter. Bruce G. Allen Investments LLC now owns 492 shares of the computer hardware maker’s stock valued at $53,000 after purchasing an additional 327 shares during the period. Legend Financial Advisors Inc. purchased a new stake in NVIDIA during the second quarter worth approximately $55,000. Finally, Campbell Capital Management Inc. grew its stake in NVIDIA by 5,900.0% during the first quarter. Campbell Capital Management Inc. now owns 600 shares of the computer hardware maker’s stock worth $65,000 after buying an additional 590 shares during the period. Institutional investors and hedge funds own 65.27% of the company’s stock.
Insider Buying and Selling at NVIDIA
In other news, Director Harvey C. Jones sold 250,000 shares of the firm’s stock in a transaction on Thursday, September 18th. The shares were sold at an average price of $176.21, for a total value of $44,052,500.00. Following the sale, the director owned 7,183,280 shares in the company, valued at approximately $1,265,765,768.80. This trade represents a 3.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Mark A. Stevens sold 350,000 shares of the firm’s stock in a transaction on Friday, September 19th. The stock was sold at an average price of $176.39, for a total transaction of $61,736,500.00. Following the completion of the sale, the director owned 7,399,803 shares in the company, valued at approximately $1,305,251,251.17. The trade was a 4.52% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 3,828,937 shares of company stock worth $680,708,026 over the last 90 days. Insiders own 4.17% of the company’s stock.
NVIDIA Price Performance
NVIDIA (NASDAQ:NVDA – Get Free Report) last posted its quarterly earnings results on Wednesday, August 27th. The computer hardware maker reported $1.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.01 by $0.04. NVIDIA had a net margin of 52.41% and a return on equity of 101.74%. The business had revenue of $46.74 billion during the quarter, compared to analyst estimates of $45.65 billion. During the same period in the prior year, the firm earned $0.68 earnings per share. The firm’s revenue was up 55.6% compared to the same quarter last year. NVIDIA has set its Q3 2026 guidance at EPS. Equities research analysts predict that NVIDIA Corporation will post 2.77 earnings per share for the current fiscal year.
NVIDIA Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 2nd. Investors of record on Thursday, September 11th were issued a $0.01 dividend. The ex-dividend date was Thursday, September 11th. This represents a $0.04 dividend on an annualized basis and a yield of 0.0%. NVIDIA’s dividend payout ratio is currently 1.14%.
Wall Street Analyst Weigh In
A number of research analysts have recently commented on the stock. Cantor Fitzgerald set a $300.00 target price on shares of NVIDIA and gave the stock an “overweight” rating in a research report on Thursday, October 9th. HSBC set a $320.00 target price on shares of NVIDIA and gave the stock a “buy” rating in a report on Wednesday. Jefferies Financial Group reissued a “buy” rating and set a $220.00 target price (up from $205.00) on shares of NVIDIA in a report on Monday, September 29th. Sanford C. Bernstein restated a “buy” rating on shares of NVIDIA in a research report on Tuesday, September 23rd. Finally, Wolfe Research increased their target price on shares of NVIDIA from $220.00 to $230.00 in a research report on Tuesday, September 23rd. Four investment analysts have rated the stock with a Strong Buy rating, thirty-nine have given a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, NVIDIA presently has an average rating of “Moderate Buy” and an average price target of $222.23.
Read Our Latest Stock Analysis on NVDA
NVIDIA Profile
NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications.
Featured Stories
- Five stocks we like better than NVIDIA
- Market Cap Calculator: How to Calculate Market Cap
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- What is the Dow Jones Industrial Average (DJIA)?
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.